The factory produces Restasis.
They’re reportedly prone to myopia.
It’s a homeopathic product.
It will expand several of its teams.
State voters rejected it by a narrow margin.
8 investors participated in the round.
Eyevance bought the product.
Its frames 'embrace the diversity of every face.'
It will provide ‘specialized and comprehensive eye care.’
It's typically prescribed for diabetes.
It comes from the Knights Templar Eye Foundation.
The association is helping states with this issue.
The company is quickly expanding its footprint.
The product was withdrawn from the market.
She has 20+ years of experience with non-profits and associations.
The company is working on a drug for major eye diseases.
It 'sets out to celebrate life’s little joys.'
She's held the role since 1996.
It will spend the money on marketing. Pair Eyewear has received a $1 million influx of funding, TechCrunch reports. The company makes customizable glasses for children. The...
The company ‘takes the warning letter seriously.’ BEDFORD, MA — Ocular Therapeutix Inc., a biopharmaceutical company focused on eye conditions, announced the receipt of a warning...